The common cutaneous reactions to EGFR inhibitors are labeled as the PRIDE syndrome (papulopustules and/ or paronychia, regulatory abnormalities of hair growth, itching, dryness due to the epidermal growth factor receptor inhibitors) [27]. This evidence concerns the gene EGFR and paronychia.